Electromed, Inc. ELMD

FY2026 · ended Jun 30, 2026 · Revenue $73.78M, +15.3% YoY · Filed Aug 25, 2026

Electromed, Inc. (ELMD) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2026, which ended Jun 30, 2026, it reported revenue of $73.8 million and net income of $11.3 million. Free cash flow was $8.4 million. As of Jun 30, 2026 it held $20.4 million in cash and investments and $133,000 in total debt.

Revenue
$73.78M
+15.3% vs prior year
Net income
$11.30M
+49.9% vs prior year
Operating cash flow
$9.66M
-15.2% vs prior year
Free cash flow
$8.41M
-24.4% vs prior year
EPS
$1.30
+52.9% vs prior year
Dividend per share
None
Shares outstanding
8.37M
+0.2% vs prior year
Net cash
$20.32M
FY 2026
Operating margin
18.8%
FY 2026

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
ELMD (NYSE)
Fiscal year ends
June 30
Incorporated in
MN
Headquarters
New Prague, MN
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1488917

Other Electromedical & Electrotherapeutic Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2026
Jun 30, 2026
FY 2025
Jun 30, 2025
FY 2024
Jun 30, 2024
FY 2023
Jun 30, 2023
FY 2022
Jun 30, 2022
Revenue
$73.8M
$64.0M
$54.7M
$48.1M
$41.7M
Operating income
$13.9M
$9.7M
$6.6M
$4.0M
$3.0M
Net income
$11.3M
$7.5M
$5.2M
$3.2M
$2.3M
Diluted EPS
$1.30
$0.85
$0.58
$0.36
$0.26
Operating cash flow
$9.7M
$11.4M
$9.1M
$1.3M
-$686,000
Free cash flow
$8.4M
$11.1M
$8.8M
-$333,000
-$2.1M
Total assets
$66.3M
$53.8M
$52.2M
$45.8M
$41.4M
Total liabilities
$12.3M
$10.6M
$7.7M
$8.1M
$7.2M
Stockholders' equity
$54.0M
$43.2M
$44.5M
$37.7M
$34.2M
Cash and investments
$20.4M
$15.3M
$16.1M
$7.4M
$8.2M
Total debt
$133,000
$198,000
$87,000
$161,000
$120,000

Recent SEC filings

Recent SEC filings
Form Description Filed Period
ARS Annual report to shareholders Sep 29, 2026 Jun 30, 2026
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Aug 25, 2026 Aug 25, 2026
10-K Annual report Aug 25, 2026 Jun 30, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 12, 2026 May 12, 2026
10-Q Quarterly report Feb 10, 2026 Dec 31, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.